Hopp til innholdet
innsidehandel

← Alle transaksjoner

Norway Royal Salmon (NRS): Mandatory notification of trade

Norway Royal Salmon ASA (NRS) · publisert 31. mars 2022 kl. 16:34 · vis på NewsWeb

Transaksjoner

PersonRolleTypeVolumPrisDatoISINHandelsplass
Klaus Hatlebrekke via Ingri Marie Sivertsen For Nyhamn AS, Business reg no.: 925 626 945Tegning Emisjon/tegning247 524202 NOK30. mars 2022NO0010331838Outside a trading venue
Klaus Hatlebrekke via Klaus Hatlebrekke, For Hatlebrekke Invest AS, Business reg no.: 996 203 263Tegning Emisjon/tegning49 500202 NOK30. mars 2022NO0010331838Outside a trading venue
Kristine Landmark StyremedlemTegning Emisjon/tegning4 754202 NOK30. mars 2022NO0010331838Outside a trading venue
Ola Loe CFOTegning Emisjon/tegning49 500202 NOK30. mars 2022NO0010331838Outside a trading venue

Vedlegg

Meldingstekst

Reference is made to the stock exchange announcement by Norway Royal Salmon ASA (the "Company") published on 31 March 2022 at 07:12 (CEST), regarding the successful private placement of new shares in the Company (the "Private Placement") at a subscription price of NOK 202 per share. The following primary insiders and their close associates have subscribed for and been allocated new shares in the Private Placement: - Ola Loe, CFO subscribed for and was allocated 49.500 shares at a subscription price of NOK 202 in the Private Placement. - Hatlebrekke Invest AS, close associate to primary insider and Interim CEO in NRS, Klaus Hatlebrekke, subscribed for and was allocated 49.500 shares at a subscription price of NOK 202 in the Private Placement. - Nyhamn AS, close associate to primary insider and board member in NRS Ingri Marie Sivertsen, subscribed for and was allocated 247.524 shares at a subscription price of NOK 202 in the Private Placement. - Kristine Landmark, board member subscribed for and was allocated 4.754 shares at a subscription price of NOK 202 in the Private Placement. . Please refer to the attached forms for further information. This notification has been submitted pursuant to MAR article 19 and the Securities Trading Act § 5-12.